Editor: What To Know
- Under the leadership of Steve Sapot, Perimeter's Chief Commercial Officer, the Company continues to build the infrastructure to support and expand its sales and marketing team, including the addition of the initial four key market development managers tasked with launching Perimeter's novel S-Series OCT medical imaging technology in the U.
- We consider the high caliber of talent that we have added to our sales team as another point of validation of Perimeter's novel imaging technology and its potential to address a significant unmet medical need in the OR.
- 4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today provided a corporate update on the progress made to date to grow its commercial organization.
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today provided a corporate update on the progress made to date to grow its commercial organization.
Under the leadership of Steve Sapot, Perimeter’s Chief Commercial Officer, the Company continues to build the infrastructure to support and expand its sales and marketing team, including the addition of the initial four key market development managers tasked with launching Perimeter’s novel S-Series OCT medical imaging technology in the U.S. market.
Steve Sapot commented, “We continue to attract top-tier sales professionals to our roster, including the addition of four highly accomplished market development managers, who bring experience from leading medtech companies including Medtronic, BD, Stanley Healthcare, and Sonosite. These core team members cover key regions in the U.S. where we have strategically identified the leading healthcare institutions that could represent the ideal early adopters of our innovative, ‘real-time’ OCT imaging technology. Our sales and marketing team is passionate about delivering Perimeter’s technology to leading U.S. physicians, with the ultimate goal of improving patient outcomes and lowering healthcare costs.”
Jeremy Sobotta, Perimeter’s Chief Executive Officer stated, “Our Chief Commercial Officer along with these first four Perimeter market development managers have impressive track records in similar ‘go-to-market’ strategies with our target customers. We consider the high caliber of talent that we have added to our sales team as another point of validation of Perimeter’s novel imaging technology and its potential to address a significant unmet medical need in the OR.”
Mr. Sobotta added, “In addition to the ongoing expansion of our sales team, our medical affairs and marketing teams have made significant progress towards establishing the foundational groundwork to support our commercial growth plans. Under the leadership of Dr. Sarah Butler, Perimeter’s VP, Clinical & Medical Affairs, we continue to execute on the clinical education strategies and activities with the aim of ensuring our customers’ success with our technology.”
